https://ksqlive.s2.designcostaging.com/ 2024-05-27T06:59:12-04:00 https://ksqlive.s2.designcostaging.com/news-events/ 2016-02-28T15:58:10-05:00 https://ksqlive.s2.designcostaging.com/oncology/ 2016-03-31T10:23:03-04:00 https://ksqlive.s2.designcostaging.com/immuno-oncology/ 2016-04-14T09:56:26-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-emerges-76-million-financing-pioneer-high-confidence-drug-development/ 2017-10-02T03:02:25-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-appoints-richard-moscicki-md-board-directors/ 2018-09-25T08:05:49-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-secures-80-million-financing-advances-broad-pipeline-cancer-therapies-including-first-adoptive-t-cell-therapy-program-pd-1-resistant-solid-tumors/ 2018-09-28T02:03:51-04:00 https://ksqlive.s2.designcostaging.com/news-events/crispr-therapeutics-and-ksq-therapeutics-announce-license-agreement/ 2019-10-15T07:22:28-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-to-present-first-data-from-its-proprietary-crispromics-discovery-engine/ 2019-10-28T10:02:53-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-enhances-board-of-directors-with-two-appointments/ 2019-11-12T08:30:01-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-to-present-at-the-piper-jaffray-31st-annual-healthcare-conference-and-provide-updates-on-immuno-oncology-and-cell-therapy-programs/ 2019-12-03T11:32:15-05:00 https://ksqlive.s2.designcostaging.com/news-events/maxcyte-and-ksq-therapeutics-announce-development-and-commercialization-agreement-to-enable-the-advancement-of-ksqs-adoptive-cell-therapy-programs/ 2019-12-04T07:08:28-05:00 https://ksqlive.s2.designcostaging.com/crispromics/ 2020-01-06T09:55:46-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-announces-discovery-of-gene-targets-with-potential-activity-superior-to-pd-1-for-development-of-engineered-tumor-infiltrating-lymphocyte-etil-therapies-for-solid-tumors/ 2020-07-06T11:55:07-04:00 https://ksqlive.s2.designcostaging.com/wp-content/uploads/2020/02/2020-Emerging-cellular-therapies-Keystone-poster-FINALv4-Sm.jpg https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-to-present-new-data-from-its-usp1-inhibitor-program-at-upcoming-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-therapeutics/ 2020-09-24T08:00:38-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-presents-first-preclinical-data-for-ksq-4279-a-novel-usp1-inhibitor-for-the-treatment-of-brca-deficient-cancers/ 2020-10-24T09:00:23-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-and-takeda-enter-broad-strategic-collaboration-to-research-develop-and-commercialize-novel-immuno-oncology-therapies/ 2021-01-13T08:27:07-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-strengthens-leadership-team-with-promotion-of-micah-benson-ph-d-to-senior-vice-president-head-of-immunobiology-and-andrew-wylie-ph-d-to-senior-vice-president-head-of-oncology/ 2021-02-01T07:00:07-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-to-present-at-the-oppenheimer-31st-annual-healthcare-conference/ 2021-03-10T07:00:34-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-appoints-qasim-rizvi-mb-chb-m-b-a-as-chief-executive-officer/ 2021-05-12T11:23:17-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-appoints-chris-heberlig-as-chief-financial-officer/ 2021-05-13T08:50:29-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-announces-first-patient-dosed-in-phase-1-study-of-ksq-4279-a-first-in-class-usp1-inhibitor-in-patients-with-advanced-solid-tumors/ 2021-09-14T08:00:38-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference/ 2021-09-22T08:00:41-04:00 https://ksqlive.s2.designcostaging.com/news-events/sitc-poster-presentation-ksq-004-unbiased-pair-wise-discovery-of-socs1-and-regnase-1-as-the-top-crispr-cas9-dual-edit-combination-enhancing-in-vivo-til-potency-against-solid-tumors/ 2021-11-22T15:32:31-05:00 https://ksqlive.s2.designcostaging.com/wp-content/uploads/2021/11/2021-KSQ-004-SITC-poster-Final.jpg https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-to-present-data-at-the-american-association-for-cancer-research-aacr-2022-annual-meeting/ 2022-03-22T09:00:03-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-announces-leadership-and-board-additions/ 2022-09-23T08:00:37-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-announces-first-patient-dosed-in-combination-portion-of-the-ongoing-phase-1-study-of-ksq-4279-a-first-in-class-usp1-inhibitor-in-patients-with-advanced-solid-tumors/ 2022-12-07T08:00:51-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-appoints-mahesh-karande-to-its-board-of-directors/ 2022-12-08T08:00:20-05:00 https://ksqlive.s2.designcostaging.com/expanded-access-policy/ 2022-12-28T11:38:53-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-announces-ono-pharmaceutical-co-ltd-is-acquiring-multiple-research-stage-oncology-programs-identified-with-ksqs-crispromics-platform-technology/ 2023-01-25T08:58:32-05:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-and-takeda-expand-strategic-immuno-oncology-collaboration-to-identify-and-validate-novel-tumor-targets/ 2023-05-17T08:00:39-04:00 https://ksqlive.s2.designcostaging.com/aacr-poster/ 2023-06-01T22:54:22-04:00 https://ksqlive.s2.designcostaging.com/aacr-2023-mechanism-of-action-paper/ 2023-06-01T23:20:17-04:00 https://ksqlive.s2.designcostaging.com/aacr-poster-2021-ksq-4279/ 2023-06-01T23:20:42-04:00 https://ksqlive.s2.designcostaging.com/aacr-presentation-new-drugs-on-the-horizon/ 2023-06-01T23:20:58-04:00 https://ksqlive.s2.designcostaging.com/sitc-poster-november-2022/ 2023-06-01T23:41:02-04:00 https://ksqlive.s2.designcostaging.com/erotc-poster-presentation/ 2023-06-01T23:57:25-04:00 https://ksqlive.s2.designcostaging.com/ena-symposium-2020/ 2023-06-01T23:58:31-04:00 https://ksqlive.s2.designcostaging.com/eortc-nic-aacr-2022/ 2023-06-02T00:00:11-04:00 https://ksqlive.s2.designcostaging.com/news-events/sitc-poster-presetnation-an-immune-crispromics-platform-enabling-genome-scale-and-pair-wise-combination-in-vivo-t-cell-function-screens-enables-comprehensive-identification-of-novel-therapeutic-tar/ 2023-06-02T12:33:24-04:00 https://ksqlive.s2.designcostaging.com/news-events/2021-sitc-poster/ 2023-06-07T14:32:26-04:00 https://ksqlive.s2.designcostaging.com/wp-content/uploads/2022/12/2021-KSQ-004-SITC-poster-Final.jpg https://ksqlive.s2.designcostaging.com/engineering-the-genome/ 2023-06-08T12:25:31-04:00 https://ksqlive.s2.designcostaging.com/nov-2022-express-poster/ 2023-06-08T12:26:43-04:00 https://ksqlive.s2.designcostaging.com/2022-hnscc-sitc-poster/ 2023-06-08T12:27:21-04:00 https://ksqlive.s2.designcostaging.com/news-events/asgct-poster-presentation-systematic-identification-of-potent-guide-rnas-with-minimal-off-target-activity-for-the-crispr-cas9-engineering-of-ksq-001-and-engineered-tumor-infiltrating-lymphocyte/ 2023-06-08T14:18:46-04:00 https://ksqlive.s2.designcostaging.com/wp-content/uploads/2020/07/ASGCT_Poster.jpg https://ksqlive.s2.designcostaging.com/news-events/aacr-poster-presentation-ksq-001-a-crispr-cas9-engineered-tumor-infiltrating-lymphocyte-etil-tm-therapy-for-solid-tumors/ 2023-06-08T14:19:38-04:00 https://ksqlive.s2.designcostaging.com/wp-content/uploads/2020/07/KSQ-001_2020AACR-Poster_04JUN2020_FINAL.jpg https://ksqlive.s2.designcostaging.com/news-events/sitc-poster-presentation-development-of-ksq-001-an-engineered-til-etil-therapy-for-solid-tumors-through-crispr-cas9-mediated-inactivation-of-socs1/ 2023-06-08T14:20:48-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-enters-worldwide-license-agreement-with-roche-for-ksq-4279-a-clinical-stage-usp1-inhibitor-for-cancer/ 2023-07-13T07:00:55-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-and-ctmc-announce-strategic-collaboration-to-accelerate-the-development-of-novel-engineered-tumor-infiltrating-lymphocyte-etil-therapies-for-the-treatment-of-solid-tumors/ 2023-09-06T07:00:06-04:00 https://ksqlive.s2.designcostaging.com/news-events/ksq-therapeutics-announces-fda-clearance-of-ind-application-for-ksq-001ex-a-crispr-cas9-engineered-tumor-infiltrating-lymphocyte-etil-therapy/ 2023-11-29T14:09:17-05:00 https://ksqlive.s2.designcostaging.com/ksq-001ex-an-engineered-til-therapy-manufactured-from-a-clinical-scale-feeder-free-process-for-the-treatment-of-solid-tumor-indications/ 2024-04-09T21:06:31-04:00 https://ksqlive.s2.designcostaging.com/publications/ 2024-04-09T21:07:26-04:00 https://ksqlive.s2.designcostaging.com/current-openings/ 2024-05-27T06:07:41-04:00 https://ksqlive.s2.designcostaging.com/contact-us/ 2024-05-27T09:55:35-04:00 https://ksqlive.s2.designcostaging.com/people/ 2024-06-03T06:11:06-04:00